BioInformant

Your Global Leader in Stem Cell Market Research

  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • News
    • Interviews
  • Advertise
  • Shop
  • Company
    • Story
    • Testimonials
    • Submit PR
    • Job Posts
    • Privacy Policy
    • Guarantee
    • Contact
Home » exosomes » Page 3

Exosomics Siena Launches Exosome-Based Liquid Biopsy Solutions for Selective Analysis of Tumor-Derived DNA and RNA

July 23, 2018 By Cade Hildreth (CEO)

Exosomics tumor-derived exosomes
  • Lonza Pharma & Biotech backs Exosomics Siena S.p.A. as they launch first products for next-generation research and diagnostic applications.

  • Exosomics Siena’s technology to bring new, highly selective solutions for cancer detection, characterization and monitoring.

Exosomics Siena tumor-derived exosomesSiena (IT) and Basel (CH), 13 July 2018 – Exosomics Siena S.p.A., a pioneer and world leader in exosome-based diagnostics, today announced the launch of its first proprietary liquid biopsy solutions, SeleCTEV™ DNA and SortEV™ RNA, for the selective isolation of tumor-derived nucleic acids from complex biofluids such as plasma or serum. [Read more…]

5 / 5 ( 3 votes )

Filed Under: Exosomes Tagged With: exosomes, Exosomics Siena, Lonza

Geographic “Hotspots” for Exosome Clinical Trials

July 10, 2018 By Cade Hildreth (CEO)

Exosome clinical trials

As exosomes become recognized for their benefits as cell-free therapeutics, exosome clinical trials are increasing in number. Exosomes are small vesicles ranging from 30-100nm in size that are found in nearly all eukaryotic fluids and facilitate a range of important cellular functions. They transfer DNA, RNA, and proteins to other cells, altering the function of target cells.

Exosome Clinical Trials

In addition to increasing in number, exosome clinical trials are tightly concentrated within specific regions of the world.

There are now 92 trials listed on ClinicalTrials.gov that contain the term “exosome” or “exosomes.” [Read more…]

5 / 5 ( 9 votes )

Filed Under: Exosomes Tagged With: clinical trials, exosomes

Bio-Techne Acquires Exosome Diagnostics for $250M Cash Plus Milestones

July 8, 2018 By Cade Hildreth (CEO)

Biotechne acquires Exosome Diagnostics

bio-techneOn June 25, 2018, Bio-Techne announced it is acquiring Exosome Diagnostics for $250 million in cash and up to $325 million for achieving certain milestones. As exosome therapeutics and diagnostics have multiplied in number, a number of investors have placed big bets on this rapidly growing marketplace.

Exosomes are small vesicles ranging from 30-100nm in size that are secreted by nearly all cell types. They facilitate a range of important cellular functions, including facilitating intercellular communication.  [Read more…]

5 / 5 ( 3 votes )

Filed Under: Exosomes, News Tagged With: Bio-techne, exosome diagnostics, exosomes

How Exosomes Are Revolutionizing Neuroimmunology with Dr. Stefano Pluchino

June 29, 2018 By Cade Hildreth (CEO)

Exosomes - Dr. Pluchino of the Pluchino Lab

 

Dr Stefano Pluchino - Pluchino Lab
Dr. Stefano Pluchino of the Pluchino Lab in Cambrige

I am honored to release this interview with Dr. Stefano Pluchino of the highly regarded Pluchino Lab in Cambridge, UK. Dr. Pluchino received his MD and PhD degrees at the University of Siena, Italy, and additional training at Cambridge University, UK.

Dr. Pluchino is an international expert on neuroimmunology-related applications of exosomes, with his lab exploring modalities by which neural progenitor cells (NPCs) engage in cell-to-cell communication. The focus of the laboratory is to explore cellular and molecular mechanisms regulating to the therapeutic plasticity of stem cells in preclinical models of CNS conditions, including multiple sclerosis (MS), stroke, and spinal cord injury. [Read more…]

5 / 5 ( 9 votes )

Filed Under: Exosomes, Interviews Tagged With: exosomes, Pluchino Lab

Dramatic Rise in Venture Capital Supporting Stem Cell Exosomes

May 29, 2018 By Cade Hildreth (CEO)

Stem cell exosomes are small vesicles ranging from 30-100nm in size that are secreted by all stem cell types. They facilitate a range of important cellular functions. As the market for stem cell exosomes has emerged, a number of investment groups have made bets on this rapidly growing marketplace. [Read more…]

Filed Under: Exosomes, News Tagged With: exosomes, venture capital

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 8
  • Next Page »

Let’s Get Social

  • Facebook
  • Twitter
  • Instagram
  • Pinterest
  • LinkedIn

Nanocellect

Aspire

Marathon Products

Cellevate

Perinatal Stem cell Society

Menu
  • Blog
  • News
  • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • US Cord Blood and Cord Tissue Storage Rates Rates of U.S. Cord Blood and Cord Tissue Storage - Historical and Projected $197
  • Global Database of Stem Cell Therapy Companies - Featuring 100+ Companies $39
  • Defining the Future of the Stem Cell Industry: Interviews with Stem Cell Executives $197 $97
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Disclaimer

Copyright © 2019 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.